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ABSTRACT Herbs have been used as food and for medicinal
purposes for centuries. Research interest has focused on various
herbs that possess hypolipidemic, antiplatelet, antitumor, or
immune-stimulating properties that may be useful adjuncts in help-
ing reduce the risk of cardiovascular disease and cancer. In different
herbs, a wide variety of active phytochemicals, including the
flavonoids, terpenoids, lignans, sulfides, polyphenolics, carotenoids,
coumarins, saponins, plant sterols, curcumins, and phthalides have
been identified. Several of these phytochemicals either inhibit nitro-
sation or the formation of DNA adducts or stimulate the activity of
protective enzymes such as the Phase II enzyme glutathione trans-
ferase (EC 2.5.1.18). Research has centered around the biochemical
activity of the Allium sp. and the Labiatae, Umbelliferae, and Zin-
giberaceae families, as well as flaxseed, licorice root, and green tea.
Many of these herbs contain potent antioxidant compounds that pro-
vide significant protection against chronic diseases. These com-
pounds may protect LDL cholesterol from oxidation, inhibit
cyclooxygenase and lipoxygenase enzymes, inhibit lipid peroxida-
tion, or have antiviral or antitumor activity. The volatile essential
oils of commonly used culinary herbs, spices, and herbal teas inhibit
mevalonate synthesis and thereby suppress cholesterol synthesis
and tumor growth. Am J Clin Nutr 1999;70(suppl):491S–9S.
KEY WORDS Herbs, herbal products, herbal medicines,
cancer, cardiovascular disease, immunity, phytochemicals, flavonoids,
terpenoids, antioxidants, garlic, licorice, green tea, flaxseed,
chronic disease prevention
INTRODUCTION
The National Institutes of Health opened its Office of Alter-
native Medicine in 1993 to provide support to qualified investi-
gators wanting to systematically study unconventional therapies.
According to a survey published by Eisenberg et al (1) in 1993,
<1 of every 3 Americans used at least one unconventional ther-
apy per year, and most of those used the unconventional therapy
for chronic rather than life-threatening medical conditions. Peo-
ple seek solutions without side effects for problems such as arthri-
tis, allergies, insomnia, headaches, anxiety, and depression (1).
Today we are witnessing a great deal of public interest in the
use of herbal remedies. Herbal medicine is based on the premise
that plants contain natural substances that can promote health
and alleviate illness. According to the Eisenberg survey (1), 3%
of the respondents had used herbal medicine within the past 12
mo. The annual sale of medicinal herbs and related commodities
in the United States now exceeds $2 billion.
In herbal medicine the term herbs is used loosely to refer not
only to herbaceous plants but also to bark; roots; leaves; seeds;
flowers and fruit of trees, shrubs, and woody vines; and extracts
of the same that are valued for their savory, aromatic, or medic-
inal qualities. The botanical term herb refers to seed-producing
plants with nonwoody stems that die down at the end of the
growing season.
Plants have played a significant role in maintaining human
health and improving the quality of human life for thousands of
years, and have served humans well as valuable components of
seasonings, beverages, cosmetics, dyes, and medicines. The World
Health Organization estimated that <80% of the earth’s inhabi-
tants rely on traditional medicine for their primary health care
needs, and most of this therapy involves the use of plant extracts
or their active components. Furthermore, many Western drugs had
their origin in a plant extract. Reserpine, which is widely used for
the treatment of high blood pressure, was originally extracted
from the plant Rauwolfia serpentina, whereas digitalis, used as a
heart stimulant, was derived from the foxglove plant (Digitalis
purpurea). The Chinese herb ephedra (Ma huang), which contains
the active substance ephedrine, was used early on for the treatment
of asthma, whereas salicylic acid (a precursor of aspirin) was
obtained from willow tree bark (Salix alba) to help relieve fevers.
Over-the-counter laxatives commonly contain psyllium, senna, or
Cascara sagrada. The laxative effect of the latter 2 herbs is due to
the presence of anthraquinones, which stimulate peristalsis,
whereas the mucilages in psyllium provide a bulking effect (2).
Paclitaxel (TAXOL; Bristol-Myers Squibb, Princeton, NJ), a
new chemotherapy agent discovered by the National Cancer
Institute screening program, is obtained from the bark of the
Pacific yew (Taxus brevifolia) as well as the needles of some
other yew species. Patients with metastatic breast cancer,
advanced lung cancer, cancers of the head and neck, melanoma,
ovarian cancer, and lymphomas have responded positively to
Taxol (3).
American Indians use several native herbs for food and for
medicinal purposes. Bee balm, black cohosh, elderberry, gin-
seng, goldenseal, mayapple, partridgeberry, ragweed, snakeroot,
and yarrow are just a few of the herbs used by American Indians
for healing (4). Self-prescribed herbal preparations are widely
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used today for a host of common ailments and conditions, such
as anxiety, arthritis, colds, coughs, constipation, fever, headaches,
infections, insomnia, intestinal disorders, premenstrual syn-
drome, stress, ulcers, and weakness. Some of the more popular
herbs in use today include Echinacea, garlic, ginseng, gold-
enseal, ginkgo, saw palmetto, aloe vera, and feverfew. Research
continues with respect to the usefulness of ginger for motion
sickness; licorice for treating ulcers; hops, passionflower, and
valerian for treating insomnia; feverfew for relieving migraine
headaches; peppermint oil for relieving irritable bowel syn-
drome; saw palmetto berries for treating benign prostatic hyper-
trophy; Echinacea for its immunostimulant properties; St John’s
Wort (containing hypericin) for anxiety and depression; and milk
thistle (with its rich content of flavono-lignans) for protecting
and restoring liver function (5–7).
Culinary herbs have also been grown and used to flavor foods
since antiquity. In most of these herbs, the flavor is provided by
the aromatic ingredients in their essential oils and oleoresins. In
addition, some herbs, ie, saffron, paprika, and turmeric, add
color to food. Government agencies and some, but not all, health
professionals recommend that for optimal health we should
reduce our salt intake. This can be achieved by flavoring our
meals to a greater degree with culinary herbs such as basil, car-
away, cilantro, coriander, cumin, dill, oregano, rosemary, sage,
thyme, and other herbal seasonings.
Whereas some herbal products may be safe and may contain
active constituents that have beneficial physiologic effects, others
may be unsafe to use. The Food and Drug Administration has clas-
sified several herbs as unsafe, even in small amounts, and hence
they should not be used in either foods or beverages (8, 9). Some
herbs are safe in modest amounts but they may become toxic at
higher doses. For example, whereas licorice root can be used
safely for treating duodenal and gastric ulcers, deaths from its
excessive use have been reported. Large amounts of licorice can
cause serious side effects such as hypokalemia, high blood pres-
sure, and heart failure (10). Other herbs are known to be lethal.
Germander, an herb used in some weight-loss programs, has been
reported to cause fatal hepatitis (11). The Chinese herbs caowu
and chuanwu are used to treat rheumatism, arthritis, bruises, and
fractures. They may contain highly toxic alkaloids such as aconi-
tine which produce neurologic, cardiovascular, and gastrointesti-
nal disturbances. Use of these herbs can even result in death (12).
HERBS FOR CARDIOVASCULAR PROBLEMS
A plant-based diet that is rich in fruit, vegetables, and legumes
and low in saturated fat, along with regular aerobic exercise pro-
gram, is a typical prescription for anyone with elevated risk of
cardiovascular disease. In addition, there are a few herbs avail-
able that provide some help for persons with either hyperlipi-
demia, an abnormal tendency to form blood clots, impaired
blood flow, or other cardiovascular problems.
Some hypercholesterolemic patients have benefited from the
use of psyllium (Plantago psyllium), a rich source of soluble
fiber (10–12% mucilage) (2). When 5 g psyllium was given
twice a day for 4 mo to subjects with blood cholesterol con-
centrations > 5.7 mmol/L (220 mg/dL), their total- and LDL-
cholesterol concentrations dropped an average of 0.26–0.39
and 0.28–0.34 mmol/L, respectively (10–15 and 11–13 mg/dL,
respectively) (13). These changes tended to be greater in sub-
jects consuming high-fat diets.
Garlic (Allium sativum L.) has been used effectively as food and
medicine for many centuries. The compound that produces much
of the activity of garlic is allicin, which is released when intact cells
of a clove are cut or crushed. Allicin inhibits a wide variety of bac-
teria, molds, yeasts (including Candida), and viruses. Research has
suggested that garlic protects against cardiovascular disease. Reg-
ular use of garlic can be effective in reducing the risk of heart
attack and stroke because it lowers total- and LDL-cholesterol and
triacylglycerol concentrations without affecting HDL-cholesterol
concentrations (14, 15). Blood lipid concentrations are also favor-
ably altered in normocholesterolemic subjects taking garlic (16).
On average, one-half to one clove of garlic per day reduces hyper-
cholesterolemia by <0.59 mmol/L (23 mg/dL) or <10% of the ini-
tial value (14). Garlic also increases fibrinolytic activity and inhibits
platelet aggregation, in part because of the presence of ajoenes,
allyl methyl trisulfide, vinyldithiins, and other sulfur compounds
produced by the breakdown of allicin (15, 17–19). Researchers in
Kuwait found that daily ingestion of 3 g garlic for 6 mo resulted in
an 80% decrease in serum thromboxane B2 and a 20% decrease in
coronary heart disease in middle-aged men (20).
The odor-modified garlic extract (Kyolic; Maxpharma, Hojb-
jerg, Denmark) has been found to be just as effective as fresh gar-
lic for lowering blood cholesterol concentrations (21). On the other
hand, dried garlic is less effective than fresh garlic or is not active
at all. The beneficial properties of garlic are typically seen when
substantial amounts are used over a period of time. Onions (Allium
cepa L.) may also be considered natural anticlotting agents because
they possess substances that have fibrinolytic activity and can sup-
press platelet aggregation (15, 17, 22). A whole family of a-sulfinyl
disulfides isolated from onions has been shown to strongly inhibit
the arachidonic acid cascade in platelets (22).
Flour derived from flaxseed (Linum usitatissimum) is popular
for use in bread and bakery products; it provides a nutty flavor and
also increases the nutritional and health benefits of the final prod-
uct. Flaxseed consumption may lower both total- and LDL-cho-
lesterol concentrations because of its low–saturated fat content,
high polyunsaturated fat and phytosterol content, and mucilage
content (2, 23). When 15 patients with elevated blood cholesterol
concentrations [>6.2 mmol/L (240 mg/dL)] consumed 15 g ground
flaxseed and 3 slices of flaxseed-containing bread daily for 3 mo,
their total- and LDL-cholesterol concentrations decreased by
<10% and platelet aggregation decreased substantially, while
their HDL-cholesterol and triacylglycerol concentrations did not
change significantly (24).
Hypercholesterolemic subjects who consumed 140 mg/d of
lemongrass (Cymbopogon citratus) oil, which is rich in geraniol
and citral, experienced a drop in cholesterol concentrations over
3 mo (25). Other isoprenoids found in common herbs have been
reported to suppress cholesterol concentrations (26). Studies of
fenugreek (Trigonella foenum-graecum) have shown that it may
also have hypocholesterolemic activity. Subjects with elevated
blood cholesterol concentrations who consumed powdered
fenugreek seeds experienced a significant reduction in LDL-
cholesterol and triacylglycerol concentrations without any
change in HDL-cholesterol concentrations (27, 28). Asian gin-
seng (Panax ginseng) is another medicinal plant with a long his-
tory of use. Researchers have discovered a nonsaponin fraction
in ginseng root that inhibits platelet aggregation by potently
inhibiting thromboxane A2 production (29).
The oil in evening primrose (Oenothera biennis) seeds con-







/ajcn/article/70/3/491s/4714940 by guest on 29 June 2021
well as high amounts (70%) of the more common a-linolenic
acid (ALA). Interest in GLA centers around its ability to enter
into prostaglandin synthesis more directly than does ALA. Some
research groups have shown that evening primrose oil (EPO)
may favorably alter blood lipid concentrations, decrease platelet
adhesiveness, and increase blood clotting time (30–33). How-
ever, it appears that commercially available EPO is often conta-
minated with other, less expensive vegetable oils that may dimin-
ish or alter its activity.
A concentrated extract of the leaves of the Ginkgo tree has
recently become a popular phytomedicine for improving cere-
bral blood flow. Ginkgo biloba extract appears to be somewhat
effective, especially in geriatric patients, against conditions
such as memory loss, dizziness, depression, confusion, and
other ailments. These conditions often respond to the vasodila-
tion and improved blood flow induced by Ginkgo extract. The
active constituents in Ginkgo, which are thought to be flavone
glycosides and diterpenoids (ginkgolides), inhibit the activity of
the platelet activating factor (5, 34, 35).
Hawthorn is another herb used for improving blood flow. The
leaves, fruit, and flowers of hawthorn (Crataegus spp.) are widely
used in Europe for improving the pumping capacity of the heart
and for treating angina. The major activity of hawthorn is thought
to be provided by various flavonoids. Hawthorn causes dilation of
the smooth muscles of the coronary vessels, thereby increasing
blood flow and reducing the tendency for angina (5). French
researchers have identified proanthocyanidins as active principles
in the flower heads of hawthorn (Crataegus oxyacantha). These
substances were reported to inhibit the biosynthesis of thrombox-
ane A2 (36). Patients with chronic heart disease who were given
600 mg/d of a hawthorn extract had lower blood pressure and
heart rates and less shortness of breath when exercising compared
with subjects not receiving hawthorn (37).
HEALTH-PROMOTING PROPERTIES OF FLAVONOIDS
Over 4000 flavonoids have been identified in plants (38).
These universal plant pigments are responsible for the colors of
flowers, fruit, and sometimes leaves (2). The commonly used
herbs that provide substantial amounts of flavonoids include
chamomile, dandelion, ginkgo, green tea, hawthorn, licorice,
passionflower, milk thistle, onions, rosemary, sage, thyme, and
yarrow. Flavonoids have extensive biological properties that pro-
mote human health and help reduce the risk of disease.
Flavonoids extend the activity of vitamin C, act as antioxidants,
protect LDL cholesterol from oxidation, inhibit platelet aggrega-
tion, and act as antiinflammatory and antitumor agents (39–41).
The Zutphen study of elderly men in the Netherlands found that
flavonoid intake from fruit, vegetables, and tea was inversely
associated with heart disease mortality and incidence of heart
attack and stroke over a 5-y period. Subjects who had the highest
consumption of flavonoids had 60% lower mortality from heart
disease and a 70% lower risk of stroke than those who consumed
low amounts of flavonoids (42, 43). Data from the 16 cohorts
participating in the Seven Countries Study revealed an inverse
relation between the average flavonoid intake and age-adjusted
mortality from heart disease after 25 y of follow-up (44).
Oxidative modification of LDL cholesterol is thought to play
a key role during atherosclerosis. Plants contain a variety of
antioxidants (including vitamins C and E and the carotenoids)
that can inhibit oxidation of LDL cholesterol. Recently, licorice
extract (free of glycyrrhizinic acid) and the isoflavan glabridin, a
major polyphenolic compound found in licorice, were shown to
markedly inhibit LDL oxidation via a mechanism involving
scavenging of free radicals (45). LDL cholesterol isolated from
10 normolipidemic subjects who consumed 100 mg licorice
extract/d for 2 wk was more resistant to oxidation than that iso-
lated from the subjects before they consumed the licorice. During
the study, total- and LDL-cholesterol concentrations and blood
coagulation remained unchanged. When glabridin (20 mg/d) or
the licorice extract was fed to atherosclerotic, apolipoprotein E–
deficient mice, there was a significant reduction after 6 wk in the
susceptibility of LDL cholesterol to oxidation and a reduction in
the incidence and extent of atherosclerotic lesions in the aortic
arch, compared with placebo-treated mice (45). The observation
that glabridin was less active than whole licorice extract could be
explained by the fact that licorice contains several other antioxi-
dants including licochalcones and other polyphenols.
Several epidemiologic studies have suggested that drinking
either green or black tea may lower blood cholesterol concentra-
tions and blood pressure, thereby providing some protection
against cardiovascular disease (46–48). When rats were fed
green tea polyphenols, blood cholesterol concentrations declined
in hypercholesterolemic animals and blood pressure decreased in
spontaneously hypertensive animals (49). Some of these effects
may be explained by the capacity of green tea catechins and gal-
late esters to reduce intestinal cholesterol absorption, lower
blood coagulability, and inhibit proliferation of human aortic
smooth muscle cells (49). Recently, LDL-cholesterol oxidation
was inhibited by exposure to tea flavonoids, specifically the cat-
echins from green tea leaves or theaflavins (catechin dimers)
from black tea leaves (50). Of the catechins, epigallocatechin
gallate provided the most protection and was more protective
than vitamin E, whereas the theaflavins exerted even stronger
inhibitory effects than the catechins.
A variety of phenolic compounds, in addition to the flavonoids,
are found in fruit, vegetables, and many herbs. These phenolics
influence the quality and stability of foods by acting as flavo-
rants, colorants, and antioxidants. The phenolic compounds
(such as caffeic, ellagic, and ferulic acids, sesamol, and vanillin)
also exhibit anticarcinogenic activity and inhibit atherosclerosis
(51). Many of the phenolic phytochemicals that have been shown
to provide protection against heart disease and cancer are
metabolites of the shikimic acid pathway (see Figure 1).
Anthocyanins are the water-soluble pigments responsible for
the red, pink, mauve, purple, blue, and violet hues of many types
of flowers and fruit. Hawthorn and juniper berries and rose hips
are examples of herbs that contain anthocyanins. Because antho-
cyanins are effective in inhibiting LDL-cholesterol oxidation and
platelet aggregation, these herbs may provide some protection
against heart disease. Anthocyanins may also be useful for the
treatment of vascular disorders and capillary fragility (2).
HELP FOR THE IMMUNE SYSTEM
Several herbal products that may enhance the function of the
immune system are available. These include Echinacea, licorice,
cat’s claw, and garlic. Herbs that are rich in flavonoids, vitamin C,
or the carotenoids may enhance immune function. The flavonoid-
rich herbs may also possess mild antiinflammatory action (2, 5).
Echinacea (purple coneflower) is an herb with a long history
of use. In the early 1900s it was the major plant-based antimi-
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crobial medicine in use. With the development of sulfa drugs, the
use of Echinacea declined rapidly. Its beneficial effect in the
treatment of infections results from its ability to act as an anti-
inflammatory agent and as an immunostimulant. It can promote
the activity of lymphocytes, increase phagocytosis, and induce
interferon production (5). Echinacea appears to be useful in
moderating the symptoms of the common cold, flu, and sore
throat. It is thought that this activity is provided by certain poly-
saccharides, flavonoids, and isobutylamides (2).
Glycyrrhizin, a sweet-tasting triterpenoid saponin, is a major
component of licorice root (Glycyrrhiza glabra L.). Glycyrrhizin
and its aglycone, glycyrrhetinic acid, have been reported to
induce interferon activity and augment natural killer cell activity
(52). Hatano and colleagues (53) reported that the chalcones in
licorice possess antiviral activity against HIV. Glycyrrhizin also
has antiinflammatory and antiallergic properties (54).
Two species of cat’s claw, Uncaria guianesis and U. tomen-
tosa, which belong to the madder family (Rubiaceae), have been
used for medicinal purposes by Peruvian Indians for over 2000 y.
Both plants grow in the northern regions of South America and
U. tomentosa also grows in Central America. Today, these plants
are attracting much attention in the West because of their
immunostimulant properties and potential to help fight AIDS and
leukemia. European researchers have suggested that these
plants enhance immune function because they contain various
flavonoids, triterpenes, or alkaloids found in the root and stalk
bark (55–57). Extracts of cat’s claw have been reported to stim-
ulate T cells, macrophages, and other components of the immune
system. The plant extracts and fractions have also been reported
to have antimutagenic and antiinflammatory properties (55, 56).
Garlic preparations have been found to exert an immunopo-
tentiating effect by stimulating natural killer cell activity (58). In
addition, 2 aromatic diones isolated from St John’s Wort (Hyper-
icum perforatum L.), hypericin and pseudohypericin, have been
reported to have potent antiretroviral activity (2, 59). It was
found that incubation of HIV with hypericin (a naphthodi-
anthrone) rendered the virus noninfectious (60). St John’s Wort
may be useful for the treatment of HIV-infected patients because
hypericin and pseudohypericin lack toxicity at therapeutic doses
(59). St John’s Wort and hypericin have also been used success-
fully for the treatment of depression (2).
HERBS WITH ANTICANCER ACTIVITY
Several commonly used herbs have been identified by the
National Cancer Institute as possessing cancer-preventive prop-
erties. These herbs include members of the Allium sp. (garlic,
onions, and chives); members of the Labiatae (mint) family
(basil, mints, oregano, rosemary, sage, and thyme); members of
the Zingiberaceae family (turmeric and ginger); licorice root;
green tea; flax; members of the Umbelliferae (carrot) family
(anise, caraway, celery, chervil, cilantro, coriander, cumin, dill,
fennel, and parsley); and tarragon (61).
Researchers have identified a host of cancer chemoprotective
phytochemicals in these herbs (Table 1). In addition, many
herbs contain a variety of phytosterols, triterpenes, flavonoids,
saponins, and carotenoids, which have been shown from studies
of legumes, fruit, and vegetables to be cancer chemoprotective
(72). These beneficial substances act as antioxidants and elec-
trophile scavengers, stimulate the immune system, inhibit
nitrosation and the formation of DNA adducts with carcinogens,
inhibit hormonal actions and metabolic pathways associated
with the development of cancer, and induce phase I or II detoxi-
fication enzymes (40, 61–64, 66, 67, 69, 72–76).
Several phytochemicals inhibit tumor formation by stimu-
lating the protective phase II enzyme, glutathione transferase
494S CRAIG
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(EC 2.5.1.18). GT is a detoxifying enzyme that catalyzes the
reaction of glutathione with electrophiles to form compounds
that are less toxic, more water-soluble, and can be excreted eas-
ily. Examples of phytochemicals that stimulate glutathione trans-
ferase activity include phthalides, found in umbelliferous herbs;
sulfides, found in garlic and onions, curcumin in turmeric and
ginger; and terpenoids, ie, limonene, geraniol, menthol, and car-
vone found in commonly used herbs (62, 72–74) (Table 2).
Research has shown that the terpenoids in plants increase tumor
latency and decrease tumor multiplicity; terpenoids also elicit a
significant reduction in total- and LDL-cholesterol concentrations,
thereby reducing the risk of heart disease (77–82, 84–87). The dif-
ferent terpenoids in various herbs possess strong antioxidant activ-
ity (65). These terpenoids, which are responsible for the unique
flavors of the herbs in the Labiatae and Umbellifereae families, are
secondary metabolites derived from mevalonate metabolism (Fig-
ure 2). Because tumor cells synthesize and accumulate cholesterol
faster than normal cells, the isoprenoids are useful cancer chemo-
preventive agents and suppress tumor growth by inhibiting HMG-
CoA reductase (77, 81, 82, 84, 85, 88, 89). In fact, Elson (78)
showed that isoprenoids inhibit tumor growth in direct proportion
to their ability to inhibit the activity of HMG-CoA reductase. Iso-
prenoids may affect tumor growth without producing any change
in blood lipid concentrations. For example, farnesol and geraniol,
and to a lesser extent perillyl alcohol, substantially suppressed the
growth of pancreatic tumor cells without significantly affecting
blood cholesterol concentrations (87).
Garlic is known to have antitumor properties, owing to its
content of a wide variety of organic sulfides and polysulfides.
Garlic is reported to enhance immune function by stimulating
lymphocytes and macrophages to destroy cancer cells; garlic is
also reported to disrupt the metabolism of tumor cells. The inhi-
bition of tumors by garlic seems to be most effective when the
tumor is small. Various studies have shown that garlic can slow
the development of bladder, skin, stomach, and colon cancers
(21, 90–92). A prospective study of 42 000 Iowa women aged
55–69 y revealed that garlic consumption was inversely associ-
ated with cancer risk. Risk of cancer in the distal colon was 50%
lower in women with the highest consumption of garlic than that
of women who did not consume garlic (93). Garlic can inhibit
the formation of nitrosamines, which are potent carcinogens, and
can also inhibit the formation of DNA adducts (94).
Scientists at the National Cancer Institute have concluded
from their collaborative studies with Chinese scientists that the
occurrence of stomach cancer is inversely related with the con-
sumption of garlic, onion, and other Allium species (95). In
northern China, where garlic production is high, people have the
lowest mortality from stomach cancer in all of China. Chinese
people in the highest quartile of intake of garlic, onions, and
other Allium herbs have a risk of stomach cancer that is 40%
lower than that of people in the lowest quartile of intake (95).
In central Georgia, where Vidalia onions are grown, mortality
rates from stomach cancer are about one-half the average US
rates (72). Case-control studies in Greece have shown that high
consumption of onions, garlic, and other Allium species. is pro-
tective against stomach cancer (72). A study in Dutch men and
women aged 55–69 y revealed that the rate of cancer in the non-
cardia section of the stomach was <50% lower in those con-
suming the highest amount of onions (at least half an onion a
day) compared with persons consuming no onions at all (96).
Flaxseed (Linum usitatissimum) contains a rich supply of lig-
nans. These plant lignans are converted to mammalian lignans
(enterolactone and enterodiol) by bacterial fermentation in the
colon (97) and they can then act as estrogens. Mammalian lig-
nans appear to be anticarcinogenic; lignan metabolites bear a
structural similarity to estrogens and can bind to estrogen recep-
tors and inhibit the growth of estrogen-stimulated breast cancer
(98–100). Urinary excretion of lignans is reduced in women with
breast cancer, whereas the consumption of flaxseed powder
increases urinary concentration of lignans several-fold (101).
Turmeric (Curcuma longa) imparts a rich yellow color to
food. Its active phenolic constituents inhibit cancer and also
have antimutagenic activity. Turmeric has been shown to sup-
press the development of stomach, breast, lung, and skin tumors
HEALTH-PROMOTING PROPERTIES OF HERBS 495S
TABLE 2
Terpenoids known to inhibit tumors1
Terpenoid Herbs that contain the active terpenoid
Carvone Caraway, spearmint, and dill
Cineole Coriander, lavender, rosemary, sage, and thyme
Farnesol Lemongrass, chamomile, and lavender
Geraniol Lemongrass, coriander, melissa, basil, and rosemary
Limonene Caraway, mints, cardamom, dill, celery seed,
coriander, and fennel
Menthol Peppermint
Perillyl alcohol Lavender, spearmint, sage
a-Pinene Caraway, coriander, fennel, juniper berry, rosemary,
and thyme
1 From references 2, 64, 76–83.
TABLE 1
Active phytochemicals found in herbs
Herbal source Active phytochemicals
Allium sp. (garlic, onions, leeks, and chives) Diallyl sulfide, disulfides, and trisulfides (62)
Labiatae family (basil, dill, fennel, marjoram, Monoterpenes, sesquiterpenes, and flavonoids (2, 62–65). Rosemary and sage contain 
mint, rosemary, oregano, sage, thyme) diterpenoids (rosmanol, carnosol, carnosic acid, rosmarinic acid, epirosmanol, and
isorosmanol), and ursolic acid (a triterpenoid) (66, 67)
Umbellifereae family (anise, caraway, celery seed, cilantro, Coumarins, phthalides, polyacetylenes, and terpenoids (63, 64, 68)
coriander, cumin, dill, fennel, and parsley)
Zingiberaceae family (turmeric and ginger) Curcumin, gingerols, and diarylheptanoids (2, 63, 69)
Green tea (2)-Epigallocatechin gallate and other catechins (63, 70, 71)
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(102, 103). Its activity is largely due to the antioxidant cur-
cumin (a diferuloylmethane), which has been shown to be an
effective antiinflammatory agent in humans (103). The rhizome
of ginger contains curcumin in addition to a dozen phenolic
compounds known as gingerols and diarylheptanoids. These
compounds possess antioxidant activity that is even greater than
that of a-tocopherol (69). Ginger also has antiemetic activity
and is used to prevent motion sickness.
Carotenoids are the pigments found in green, leafy herbs; rose
hips; and the herbs used as coloring agents, such as paprika, saf-
fron, and annatto. The carotenoid pigments are effective antiox-
idants that quench free radicals, provide protection against
oxidative damage to cells, and also stimulate immune function.
Persons with high serum concentrations of carotenoids have
reduced risk of both heart disease and cancer (104–106).
Polyphenolics in green tea (Camellia sinensis) are known to
possess antimutagenic and anticancer activity. Some evidence
suggests that tea has a protective effect against stomach and colon
cancers (49). Animal studies also suggest that the risk of cancer
in several organs is reduced by consumption of green and black
tea or their principal catechins (49). The tumor incidence and
average tumor yield in rats with chemically induced colon cancer
were significantly reduced when the rats received (2)-epigallo-
catechin gallate, a major polyphenolic constituent of green tea
(71). In a study conducted at the New Jersey Medical School,
extracts of both black and green tea significantly inhibited
leukemia and liver tumor cells from synthesizing DNA (107).
Green and black tea are also reported to possess antifungal,
antibacterial, and antiviral activity (49).
Korean studies suggest that ginseng (Panax ginseng) may
lower the risk of cancer in humans (108). Ginseng extract and
powder have been found to be more effective than fresh sliced
ginseng, ginseng juice, or ginseng tea for reducing the risk of
cancer (109). In a large-scale, case-control study in Korea,
researchers observed that the incidence of human cancer decreased
steadily with duration of ginseng use and total lifetime use of gin-
seng. Subjects who had taken ginseng for 1 y had a 36% lower
incidence of cancer than nonusers, whereas those who had used
ginseng for 5 y or more had a 69% lower incidence. Furthermore,
those who had used ginseng <50 times during their lives had a
45% lower incidence of cancer, whereas those who had used gin-
seng >500 times in their lives had a 72% lower incidence (110).
Ginseng seemed to be most protective against cancer of the
ovaries, larynx, pancreas, esophagus, and stomach and less effec-
tive against breast, cervical, bladder, and thyroid cancers. The
main active ingredients in ginseng root are thought to be a family
of 6 triterpene saponins called ginsenosides (2). Other active con-
stituents that may help reduce cancer risk include flavonoids,
polysaccharides, and polyacetylenes (108).
Lentinan, a b-glucan found in shiitake mushrooms (Lentinus
edodes), has been shown to have antitumor activity; it was active
against lung carcinoma and 2 human melanomas (111). It is
thought that lentinan has its effects by activating the host immune
system. Lentinan stimulates increased production and activity of
natural killer cells and macrophages, which destroy tumor cells
(112). Preliminary studies also suggest that shiitake extracts pos-
sess hypolipidemic and antithrombotic activity (112). Screening
tests on fungi belonging to the Polyporaceae family have identified
several compounds with antitumor activity, including a variety of
terpenoids and steroids, polysaccharides, and an organic germa-
nium compound (113). Several other edible mushrooms are
reported to have antitumor activity and other useful medicinal
properties such as hypotensive action, antithrombotic activity, anti-
inflammatory effects, and ability to improve hyperlipidemia (114).
Phytomedicinals that have no proven value in the treatment of
cancer are apricot pits (their laetrile content has no antitumor
activity), pau d’arco (lapachol and its derivatives are actually
toxic), and mistletoe (both the American and European mistle-
toes actually contain toxic polypeptides) (5).
CONCLUSION
A variety of herbs and herbal extracts contain different phyto-
chemicals with biological activity that can provide therapeutic
effects. Several herbs can help to reduce high blood cholesterol
concentrations, provide some protection against cancer, and stim-
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ulate the immune system. Furthermore, a diet in which culinary
herbs are used generously to flavor food provides a variety of
active phytochemicals that promote health and protect against
chronic diseases. Charlemagne was correct when he said “a herb
is a friend of physicians and the praise of cooks” (115). The dis-
criminate and proper use of some herbal products is safe and may
provide some therapeutic benefits, but the indiscriminate or exces-
sive use of herbs can be unsafe and even dangerous (5).
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